v3.25.2
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Convertible debt
Warrant
Private placement
At-the-market distribution
Common Stock
Common Stock
Convertible debt
Common Stock
Warrant
Common Stock
Private placement
Common Stock
At-the-market distribution
Equity Portion of Convertible Promissory Note
Equity Portion of Convertible Promissory Note
Convertible debt
Additional Paid- in-Capital
Additional Paid- in-Capital
Warrant
Accumulated Deficit
Accumulated Other Comprehensive Loss
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2023           165,134,000                      
Beginning balance at Dec. 31, 2023 $ 261,966         $ 308,198         $ 3,813   $ 41,203   $ (89,456) $ (1,792) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net loss (7,742)                           (7,282)   (460)
Shares issued (in shares)                 2,564,000 496,000              
Shares issued       $ 10,000 $ 2,008       $ 10,000 $ 2,008              
Share issuance costs (50)         $ (50)                      
Shares issued for exercise of warrants / Equity portion of convertible promissory note (in shares)             6,872,000 5,579,000                  
Shares issued for exercise of warrants / Equity portion of convertible promissory note   $ 19,304 $ 16,934       $ 23,117 $ 22,297       $ (3,813)   $ (5,363)      
Shares issued for exercise of stock options (in shares)           698,000                      
Shares issued for exercise of stock options 901         $ 2,009             (1,108)        
Share-based compensation 818                       818        
Non-controlling interest Investment in Alta Mesa JV 55,011                       15,458       39,553
Cumulative translation adjustment 202                             202  
Ending balance (in shares) at Mar. 31, 2024           181,343,000                      
Ending balance at Mar. 31, 2024 359,352         $ 367,579         0   51,008   (96,738) (1,590) 39,093
Beginning balance (in shares) at Dec. 31, 2023           165,134,000                      
Beginning balance at Dec. 31, 2023 261,966         $ 308,198         3,813   41,203   (89,456) (1,792) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net loss (31,363)                                
Shares issued (in shares)         495,765                        
Shares issued for exercise of warrants / Equity portion of convertible promissory note (in shares)           7,467,735                      
Shares issued for exercise of warrants / Equity portion of convertible promissory note                         $ (6,840)        
Shares issued for exercise of stock options (in shares)           1,936,867             (1,489,000)        
Share-based compensation                         $ 1,703        
Cumulative translation adjustment (915)                                
Ending balance (in shares) at Jun. 30, 2024           184,470,000                      
Ending balance at Jun. 30, 2024 345,033         $ 375,097         0   53,909   (118,757) (2,707) 37,491
Beginning balance (in shares) at Mar. 31, 2024           181,343,000                      
Beginning balance at Mar. 31, 2024 359,352         $ 367,579         0   51,008   (96,738) (1,590) 39,093
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net loss (23,621)                           (22,019)   (1,602)
Contributions from non-controlling interest 3,874                       3,874        
Shares issued for exercise of warrants / Equity portion of convertible promissory note (in shares)           1,888,350   1,888,000                  
Shares issued for exercise of warrants / Equity portion of convertible promissory note     $ 5,120         $ 6,597         $ (1,477) $ (1,477)      
Shares issued for exercise of stock options (in shares)           1,239,113             (381,000)        
Shares issued for exercise of stock options 540         $ 921             $ (381)        
Share-based compensation 885                       885        
Cumulative translation adjustment (1,117)                             (1,117)  
Ending balance (in shares) at Jun. 30, 2024           184,470,000                      
Ending balance at Jun. 30, 2024 $ 345,033         $ 375,097         0   53,909   (118,757) (2,707) 37,491
Beginning balance (in shares) at Dec. 31, 2024 186,114,948         186,115,000                      
Beginning balance at Dec. 31, 2024 $ 318,542         $ 380,325         0   59,856   (150,848) (3,597) 32,806
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net loss (25,387)                           (24,243)   (1,144)
Contributions from non-controlling interest 6,502                       5,045       1,457
Inventory transfers to non-controlling interest (1,053)                               (1,053)
Shares issued for exercise of warrants / Equity portion of convertible promissory note (in shares)               90,000                  
Shares issued for exercise of warrants / Equity portion of convertible promissory note               $ 302         (66)        
Shares issued for exercise of stock options (in shares)           181,000                      
Shares issued for exercise of stock options 141         $ 241             (100)        
Share-based compensation 878                       878        
Cumulative translation adjustment 65                             65  
Ending balance (in shares) at Mar. 31, 2025           186,386,000                      
Ending balance at Mar. 31, 2025 $ 299,924         $ 380,868         0   65,613   (175,091) (3,532) 32,066
Beginning balance (in shares) at Dec. 31, 2024 186,114,948         186,115,000                      
Beginning balance at Dec. 31, 2024 $ 318,542         $ 380,325         0   $ 59,856   (150,848) (3,597) 32,806
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net loss $ (34,222)                                
Shares issued for exercise of warrants / Equity portion of convertible promissory note (in shares)           90,000                      
Shares issued for exercise of stock options (in shares) 853,376         853,376             (544,000)        
Share-based compensation                         $ 1,629        
Cumulative translation adjustment $ 1,329                                
Ending balance (in shares) at Jun. 30, 2025 187,058,324         187,058,000                      
Ending balance at Jun. 30, 2025 $ 294,919         $ 381,861         0   66,500   (181,417) (2,268) 30,243
Beginning balance (in shares) at Mar. 31, 2025           186,386,000                      
Beginning balance at Mar. 31, 2025 299,924         $ 380,868         0   65,613   (175,091) (3,532) 32,066
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net loss (8,835)                           (6,326)   (2,509)
Contributions from non-controlling interest 2,773                       $ 580       2,193
Inventory transfers to non-controlling interest (1,507)                               (1,507)
Shares issued for exercise of stock options (in shares)           672,043             (444,000)        
Shares issued for exercise of stock options 549         $ 993             $ (444)        
Share-based compensation 751                       751        
Cumulative translation adjustment $ 1,264                             1,264  
Ending balance (in shares) at Jun. 30, 2025 187,058,324         187,058,000                      
Ending balance at Jun. 30, 2025 $ 294,919         $ 381,861         $ 0   $ 66,500   $ (181,417) $ (2,268) $ 30,243